A recent blog post from Imprivata on electronic prescribing of controlled substances.
Editor's Note: This article was originally posted on Imprivata's website.
On October 24, 2018, the “SUPPORT for Patients and Communities Act” was signed into law. As part of the sweeping bill aimed at addressing the national opioid crisis, the new federal legislation includes an electronic prescribing requirement for all controlled substance prescriptions covered under a Medicare part D prescription drug plan (or an MA–PD plan). The deadline to comply with this section of the new law is January 1, 2021. Given the challenges of aligning with these new requirements, the pressing question for all healthcare organizations becomes clear: are you ready?
News From Our Partners